TOP - Daily
According to the US Food and Drug Administration (FDA), 2 additional cases of progressive multifocal leukoencephalopathy (PML) have been reported with the lymphoma drug Adcetris (brentuximab vedotin).
Due to the serious nature of PML, a new boxed warning highlighting this risk has been added to the drug label.
In addition, a new contraindication warning against use of Adcetris with bleomycin due to increased risk of pulmonary toxicity has also been added to the drug label.
Read More ›To help meet the distinct healthcare requirements of children and adolescents, America’s biopharmaceutical companies are currently researching 282 medicines, according to a new report recently released by the Pharmaceutical Research and Manufacturers of America (PhRMA).
Read More ›A new study from the University of Reading in England highlights concerns over whether parabens could contribute to breast cancer since they are able to imitate the female hormone estrogen, which is known to promote the growth of breast tumors.
Read More ›The importance of creating social and physical environments that support healthy behaviors is central to the updated nutrition and physical activity guidelines for cancer prevention from the American Cancer Society (ACS). The report includes updated advice for personal diet and physical activity patterns, but it emphasizes that the community in which those choices are made can either facilitate or impede healthy behaviors.
Read More ›
A Cedars-Sinai study found that chemicals in the skins and seeds of red grapes decreased estrogen levels slightly while increasing testosterone among premenopausal women who drank 8 ounces of red wine nightly for about a month.
The study, published online in the Journal of Women’s Health, challenges the widely held belief among doctors that all alcohol increases estrogen levels, thus nurturing the growth of cancer cells.
Read More ›As drug companies search for innovative approaches to increase the speed and reduce the cost of drug development, the greatest advances will derive from improved coordination with development partners and enhanced clinical trial design, according to the Tufts Center for the Study of Drug Development (CSDD).
Read More ›With the addition of everolimus (Afinitor®) to exemestane, postmenopausal women whose advanced breast cancer no longer responded to hormonal therapy lived approximately 4 months longer without disease progression compared with women who received exemestane alone.
Read More ›A physical therapist can significantly reduce costs and the need for intensive rehabilitation by diagnosing and treating breast cancer-related lymphedema early, according to an article published in the January issue of Physical Therapy, the scientific journal of the American Physical Therapy Association (APTA).
Read More ›According to new research, annual prostate cancer screening among men in their 50s and 60s and those with underlying health conditions does not reduce deaths from the disease.
Read More ›When blood clots develop in cancer patients, 78% of the time they occur when a person is out of the hospital, while on chemotherapy. This remarkable fact comes from a study of nearly 18,000 cancer patients by researchers at the University of Rochester Medical Center (URMC).
Read More ›